Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of the Prefectural University of Hiroshima (15MH064) and Kobe University Graduate School of Health Sciences (277-2). Furthermore, the trial was registered at the University Hospital Medical Information Network (UMIN) Center (ID: UMIN000020459).